Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) studyPierre‐François Laterre, Haikel Oueslati, Peter Pickkers et al.|Critical Care|2018Cited by 134
Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) StudyAlexa Hollinger, Matthieu Legrand, Xavier Wittebole et al.|Kidney International Reports|2018Cited by 108
Circulating Dipeptidyl Peptidase 3 is a Myocardial Depressant Factor: Dipeptidyl Peptidase 3 Inhibition Rapidly and Sustainably Improves HaemodynamicsBenjamin Deniau, Alice Blet, Linda Rehfeld et al.|European Journal of Heart Failure|2019Cited by 106
Circulating Dipeptidyl Peptidase 3 and Alteration in Haemodynamics in Cardiogenic Shock: Results from the OptimaCC TrialKoji Takagi, Antoine Kimmoun, Alice Blet et al.|European Journal of Heart Failure|2019Cited by 97
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre‐François Laterre, Anne-Aurore Duchambon, Peter Pickkers et al.|Intensive Care Medicine|2021Cited by 92